KEGG   DRUG: Gosuranemab
Entry
D11293                      Drug                                   
Name
Gosuranemab (USAN);
Gosuranemab (genetical recombination) (JAN)
Formula
C6434H9930N1706O2014S48
Exact mass
144853.3643
Mol weight
144943.0298
Sequence
(Heavy chain)
EVHLVESGGA LVKPGGSLRL SCAASGFSFS KYGMSWVRQA PGKGLEWVAT ISSSGSRTYY
PDSVKGRFTI SRDNAKNTLY LQMNSLRAED TAMYYCSISW DGAMDYWGQG TTVTVSSAST
KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE FLGGPSVFLF
PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTYRVV
SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP SQEEMTKNQV
SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD KSRWQEGNVF
SCSVMHEALH NHYTQKSLSL SLGK
(Light chain)
DVVMTQSPLS LPVTLGQPAS ISCKSSQSIV HSNGNTYLEW YLQKPGQSPQ LLVYKVSNRF
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGT YYCFQGSLVP WAFGGGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H131-L219, H144-H200, H223-H'223, H226-H'226, H258-H318, H364-H422, H'22-H'96, H'131-L'219, H'144-H'200, H'258-H'318, H'364-H'422, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Anti-tau protein antibody
  Type
Monoclonal antibody
Comment
Treatment of progressive supranuclear palsy (PSP) and other tauopathies
Target
MAPT (TAU) [HSA:4137] [KO:K04380]
  Pathway
hsa04010  MAPK signaling pathway
hsa05010  Alzheimer disease
hsa05022  Pathways of neurodegeneration - multiple diseases
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    MAPT (TAU)
     D11293  Gosuranemab (USAN)
Other DBs
CAS: 1788032-39-2
PubChem: 384585271
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system